Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination in Females Aged 9-25 Years in the US

NCT01153906 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01153906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01153906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination in Females Aged 9-25 Years in the US
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
September 30, 2013
Enrollment
1,516 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus